Octisalate

Octisalate

SCHEMBL29637131

CCCCC(CC)COC(=O)c1ccccc1O.CCCCCCOc1c(CC)cccc1C(=O)O

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.68
PRSS1 P07477 1/20 0.58
PRSS2 P07478 1/20 0.58
PRSS3 P35030 1/20 0.58
ALDH1A1 P00352 7/20 0.57
CYP3A4 P08684 3/20 0.57
CA2 P00918 1/20 0.57
TSHR P16473 3/20 0.45
MAPK1 P28482 3/20 0.45
TP53 P04637 1/20 0.41
HSD17B10 Q99714 2/20 0.41
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PTPN11 Q06124 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29378735 0.87 TSHR (0.58) LMNAALDH1A1CYP3A4TSHRMAPK1
Octisalate SCHEMBL1946017 0.86 LMNA (0.73) LMNAPRSS1PRSS2PRSS3ALDH1A1
Octisalate SCHEMBL29428934 0.86 LMNA (0.73) LMNAPRSS1PRSS2PRSS3ALDH1A1
Octisalate SCHEMBL6023812 0.85 LMNA (0.86) LMNAPRSS1PRSS2PRSS3ALDH1A1
Octisalate SCHEMBL20395019 0.85 LMNA (0.90) LMNAPRSS1PRSS2PRSS3ALDH1A1
Octisalate SCHEMBL6853192 0.85 LMNA (0.90) LMNAPRSS1PRSS2PRSS3ALDH1A1
Salicylic Acid SCHEMBL30211364 0.84 PTPN11 (0.49) LMNAALDH1A1CA2TSHRKDM4E
Salicylic Acid SCHEMBL15203964 0.84 PTPN11 (0.49) LMNAALDH1A1CA2TSHRKDM4E
SCHEMBL29860353 0.83 ALDH1A1 (0.48) LMNAPRSS1PRSS2PRSS3ALDH1A1
SCHEMBL1963593 0.82 LMNA (0.90) LMNAPRSS1PRSS2PRSS3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4103144-B1 COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS SYMRISE AG (DE) 2026-05-27 EP disclosed
EP-4706780-A2 COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS Symrise AG (DE) 2026-03-11 EP disclosed
US-20260034042-A1 Composition with Improved SPF and UVA Photoprotection SYMRISE AG (DE) 2026-02-05 US disclosed
EP-4676428-A1 LIQUID UV FILTER COMPOSITION CONTAINING DIOLS Symrise AG (DE) 2026-01-14 EP disclosed
EP-4676433-A1 LIQUID UV FILTER CONCENTRATE Symrise AG (DE) 2026-01-14 EP disclosed
EP-4616840-A2 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION Symrise AG (DE) 2025-09-17 EP disclosed
EP-4103288-B1 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION SYMRISE AG (DE) 2025-07-30 EP disclosed
EP-4582079-A2 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION Symrise AG (DE) 2025-07-09 EP disclosed
EP-4565192-A1 COMPOSITION WITH IMPROVED SPF AND UVA PHOTOPROTECTION Symrise AG (DE) 2025-06-11 EP disclosed
EP-4565191-A1 COMPOSITION COMPRISING A UV-FILTER STABILIZER Symrise AG (DE) 2025-06-11 EP disclosed
CN-116528824-A Composition comprising an ultraviolet filter and one or more (bio) -alkanediols 西姆莱斯股份公司 2023-08-01 CN disclosed
EP-4103288-A1 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION Symrise AG (DE) 2022-12-21 EP disclosed
EP-4103144-A1 COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS Symrise AG (DE) 2022-12-21 EP disclosed
EP-4103143-A1 COMPOSITIONS COMPRISING NATURAL POLYMERS AND ONE OR MORE (BIO)-ALKANEDIOLS Symrise AG (DE) 2022-12-21 EP disclosed
WO-2022122894-A1 COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS SYMRISE AG (DE) 2022-06-16 WO disclosed
WO-2022122135-A1 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION SYMRISE AG (DE) 2022-06-16 WO disclosed
WO-2022122890-A1 COMPOSITIONS COMPRISING NATURAL POLYMERS AND ONE OR MORE (BIO)-ALKANEDIOLS SYMRISE AG (DE) 2022-06-16 WO disclosed
WO-2022122132-A1 COMPOSITIONS COMPRISING NATURAL POLYMERS AND ONE OR MORE (BIO)-ALKANEDIOLS SYMRISE AG (DE) 2022-06-16 WO disclosed
WO-2022122133-A1 COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS SYMRISE AG (DE) 2022-06-16 WO disclosed
WO-2022122930-A1 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION SYMRISE AG (DE) 2022-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260034042-A1 Composition with Improved SPF and UVA Photoprotection TYR, ERG28, CUTA LMNA 1465/4885PRSS1 3820/4885PRSS2 3959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.